EORTC GUCG Group
FEASIBILITY FORM: EORTC trial "1407"
“TIGER: A randomised phase III trial comparing conventional-Dose chemotherapy using paclitaxel, ifosfamide, and cisplatin (TIP) with high dose chemotherapy using mobilizing paclitaxel followed by High-dose carboplatin and etoposide (TI-CE) as first salvage treatment in relapsed or refractory germ cell tumours"
Projected start: Q1. 2015
THIS FEASIBILITY IS CLOSED